Bautista-Molano, Wilson http://orcid.org/0000-0003-0684-9542
Fernández-Ávila, Daniel G.
Brance, María Lorena http://orcid.org/0000-0002-6749-9921
Ávila Pedretti, María Gabriela
Burgos-Vargas, Ruben
Corbacho, Inés
Cosentino, Vanesa Laura http://orcid.org/0000-0002-4739-4698
Díaz Coto, José Francisco
Giraldo Ho, Enrique http://orcid.org/0009-0000-4667-6784
Gomes Resende, Gustavo http://orcid.org/0000-0001-6566-9280
Gutiérrez, Luis Arturo
Gutiérrez, Marwin http://orcid.org/0000-0002-7995-1110
Ibáñez Vodnizza, Sebastián Eduardo http://orcid.org/0000-0002-9577-3078
Jáuregui, Edwin http://orcid.org/0000-0002-0643-6337
Ocampo, Vanessa
Palleiro Rivero, Daniel Ruben http://orcid.org/0000-0001-9526-5527
Palominos, Penélope Esther
Pacheco Tena, Cesar
Quiceno, Guillermo Andrés
Saldarriaga-Rivera, Lina María
Sommerfleck, Fernando Andrés http://orcid.org/0000-0001-6863-7559
Goecke Sariego, Annelise http://orcid.org/0000-0001-6832-3728
Vera Barrezueta, Claudia http://orcid.org/0000-0002-9374-4054
Vega Espinoza, Luis Enrique
Vega Hinojosa, Oscar http://orcid.org/0000-0002-9108-0389
Citera, Gustavo http://orcid.org/0000-0002-3724-1874
Lozada, Carlos http://orcid.org/0000-0001-7340-7264
Sampaio-Barros, Percival D.
Schneeberger, Emilce http://orcid.org/0000-0001-7671-5748
Soriano, Enrique R. http://orcid.org/0000-0003-3143-1084
Article History
Accepted: 5 September 2023
First Online: 6 October 2023
Competing interests
: W.B.M. declares that he has been a speaker and/or participated in Advisory Boards for AbbVie, Amgen, Biopas, Bristol Myers Squibb, Eli Lilly, Janssen, Novartis and Pfizer. D.G.F.Á. declares that he has been a speaker for AbbVie, Biopas, Bristol Myers Squibb, Janssen, Lilly, Pfizer and Roche, and that patent No. 13215332 has been granted in his name by the Superintendencia de Industria y Comercio de “Simulador anatómico de hallazgos semiológicos en enfermedades reumáticas” (Calificación internacional de patentes: A61F 2/58, effective from 9 November 2013 to 9 November 2023). M.G.Á.P. declares that she has received funding from INDEX and Pfizer for conference attendance. M.G. declares that he has attended advisory board meetings, scientific consultancies and has obtained speaking fees for AbbVie, Novartis, UCB, Esaote SpA, Janssen, Bristol-Myers Squibb, Merck Sharp & Dohme, Pfizer and Sanofi Aventis. E.G.H. declares that he has participated in Advisory Boards for Novartis. S.E.I.V. declares that he has participated in an Advisory Board and has been a speaker for AbbVie, Bristol Myers Squibb and Novartis. E.J. declares that he has received funding from AbbVie to attend academic events. V.O. declares that she was a speaker for AbbVie in 2020 in rheumatology and uveitis programs. P.E.P. declares that she has participated in Advisory Boards for Janssen; has received funding from AbbVie, Janssen, Novartis, Pfizer and Roche for conference attendance; and received financial support from AbbVie to complete a Master’s degree in spondyloarthritis at Universidad Europea de Madrid. D.R.P.R. declares that he has received funding from Janssen and Novartis to attend academic events. G.A.Q. declares that his wife is Medical Director at Janssen Pharmaceuticals. F.A.S. declares that he has been a speaker for AbbVie, Janssen, Novartis, Lilly and Tecnofarma. C.V.B. declares that she has been a speaker for Bago, MSD, Janssen, Medicamenta, Novartis, Pfizer and Roche and has participated in randomized clinical trials sponsored by MSD and Eli Lilly. I.C. declares that she has participated in events and advisory board for AbbVie. V.L.C. declares that she has been a speaker and participated in academic events for AbbVie, Janssen and Novartis. A.G.S. declares that she has been a speaker for AbbVie, Biopas and Novartis; has received advisory board payments from Johnson & Johnson; is an AbbVie-funded Protocol Investigator and was a Pfizer-funded protocol investigator until 2021. G.G.R. declares that he has been a speaker and participated in Advisory Boards for AbbVie, Janssen, Eli Lilly and Novartis. L.M.S.R. declares that she has been a speaker for Amgen, Biopas, Boehringer, Bristol Myers Squibb, Genzyme, Janssen, Eli Lilly, Novartis, Pfizer, Roche and Sanofi. C.P.T. declares that he has received speaker fees from and/or has participated in research protocols for AbbVie, Eli Lilly, Gilead, Janssen, UCB, Novartis and Pfizer. E.S. declares that she has participated in advisory boards, given conferences or received grants from AbbVie, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly, Janssen, Novartis, Pfizer and Raffo. G.C. declares that he has participated in advisory boards, given conferences or received grants from AbbVie, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly, Genzyme, Gema Biotech, Glaxo, Janssen, Pfizer, Raffo, Roche and Sandoz. P.D.S.B. declares that he has participated in advisory boards, given conferences or received grants from AbbVie, Boehringer Ingelheim, Celltrion, Eli Lilly, Glaxo SmithKline, Novartis, Pfizer, Sandoz and UCB. E.R.S. declares that he has participated in advisory boards, conferences or received grants from AbbVie, Amgen, Bristol Myers Squibb, Genzyme, Glaxo, Janssen, Lilly, Novartis, Pfizer, Roche, Sandoz, Sanofi and UCB. M.L.B., R.B.V., J.F.D.C., L.A.G., L.E.V.E. and O.V.H. declare no competing interests.
Free to read: This content has been made available to all.